Atlas Trials

Long-term Outcome of HER2-amplified Metastatic Breast Cancer: A Retrospective Analysis

Clinical trial NCT02560311 · UNKNOWN

Trial details

NCT number
NCT02560311
Sponsor
University of Zurich
Status
UNKNOWN
Study type
OBSERVATIONAL
ERBB2Breast CancerMetastatic Neoplasm
Start date
2014-12-01
Primary completion
2015-09-01
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.